White Blood Cell


Cell Therapy Manufacturing & Gene Therapy Congress

Kite talks audits, training and dry runs across CAR T supply chain

By Dan Stanton

CAR T developers must be involved throughout the entire supply chain says Kite Pharma, which depends on accreditation and training programmes across its network of Yescarta administration clinics.

Neutrophils: Stada and Apotex to enter crowded EU filgrastim  market


Stada to sell Apotex' biosimilar filgrastim in Europe

By Gareth Macdonald

Stada Arzneimittel has licensed European rights to a biosimilar version of the white blood cell booster filgrastim from Apotex and says it is not worried by competitors already in the market.